Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Y Donath

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Trends in Endocrinology and Metabolism: TEM|September 29, 2015
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular ComplicationsChristian Herder, Elise Dalmas, Marianne Böni-Schnetzler, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 25, 2003
Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetesMarc Y Donath, Joachim Størling, Kathrin Maedler, et al.
Diabetes Care|July 22, 2016
Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular ComplicationsRena M Pollack, Marc Y Donath, Derek LeRoith, et al.
Diabetologia|November 4, 2024
Targeting the NLRP3 inflammasome-IL-1β pathway in type 2 diabetes and obesityDaniel T Meier, Joyce de Paula Souza, Marc Y Donath
Journal of Diabetes and Its Complications|July 4, 2015
Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitusKatharina Timper, Eleonora Seelig, Dimitrios A Tsakiris, et al.
Archives of Physiology and Biochemistry|August 4, 2009
Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunctionJan A Ehses, Helga Ellingsgaard, Marianne Böni-Schnetzler, et al.
Biochemical Society Transactions|May 17, 2008
Macrophages, cytokines and beta-cell death in Type 2 diabetesJan A Ehses, Marianne Böni-Schnetzler, Mirjam Faulenbach, et al.
Swiss Medical Weekly|November 20, 2004
Islets secretory capacity determines glucose homoeostasis in the face of insulin resistancePeter Wiesli, Evelyne Schäffler, Burkhardt Seifert, et al.
Physiology (Bethesda, Md.)|December 10, 2009
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetesMarc Y Donath, Marianne Böni-Schnetzler, Helga Ellingsgaard, et al.
Cell Metabolism|June 11, 2013
Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunityMarc Y Donath, Élise Dalmas, Nadine S Sauter, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Trends in Endocrinology and Metabolism: TEM|September 29, 2015
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular ComplicationsChristian Herder, Elise Dalmas, Marianne Böni-Schnetzler, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 25, 2003
Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetesMarc Y Donath, Joachim Størling, Kathrin Maedler, et al.
Diabetes Care|July 22, 2016
Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular ComplicationsRena M Pollack, Marc Y Donath, Derek LeRoith, et al.
Diabetologia|November 4, 2024
Targeting the NLRP3 inflammasome-IL-1β pathway in type 2 diabetes and obesityDaniel T Meier, Joyce de Paula Souza, Marc Y Donath
Journal of Diabetes and Its Complications|July 4, 2015
Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitusKatharina Timper, Eleonora Seelig, Dimitrios A Tsakiris, et al.
Archives of Physiology and Biochemistry|August 4, 2009
Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunctionJan A Ehses, Helga Ellingsgaard, Marianne Böni-Schnetzler, et al.
Biochemical Society Transactions|May 17, 2008
Macrophages, cytokines and beta-cell death in Type 2 diabetesJan A Ehses, Marianne Böni-Schnetzler, Mirjam Faulenbach, et al.
Swiss Medical Weekly|November 20, 2004
Islets secretory capacity determines glucose homoeostasis in the face of insulin resistancePeter Wiesli, Evelyne Schäffler, Burkhardt Seifert, et al.
Physiology (Bethesda, Md.)|December 10, 2009
Islet inflammation impairs the pancreatic beta-cell in type 2 diabetesMarc Y Donath, Marianne Böni-Schnetzler, Helga Ellingsgaard, et al.
Cell Metabolism|June 11, 2013
Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunityMarc Y Donath, Élise Dalmas, Nadine S Sauter, et al.
Pageof 13